News & Alerts
-
Jun- 2023 -28 June
Retatrutide: The Drug That Beats Ozempic, Mounjaro, Wegovy for Weight Loss
Eli Lilly, a renowned pharmaceutical company, has unveiled an extraordinary breakthrough in weight loss treatment. Through a new study, participants…
Read More » -
27 June
These 7 Drugs Are Currently Scarce
Of the hundreds of ongoing drug shortages in the U.S., some of the most concerning cases involve lifesaving cancer medications,…
Read More » -
27 June
High-Dose Oral Semaglutide Shows Similar Efficacy as Injectable Versions – Study
The results of two Phase 3 clinical trials, OASIS and PIONEER PLUS, suggest that higher doses of oral semaglutide may…
Read More » -
27 June
Ketone Supplements Linked to Cardiorespiratory Stress – Study
The use of ketone supplements by athletes as a means to enhance their performance has been a subject of debate…
Read More » -
27 June
Ozempic, Wegovy Face Stiff Challenge From Mounjaro, Orforglipron, and CagriSema for Weight Loss
The introduction of Wegovy, a weight-loss formulation derived from Novo Nordisk’s diabetes drug Ozempic, has led to a surge in…
Read More » -
27 June
FDA Approves Talzenna (Talazoparib) For Castration-Resistant Prostate Cancer
The U.S. Food and Drug Administration (FDA) has granted approval to Talzenna (talazoparib) in combination with enzalutamide for the treatment…
Read More » -
24 June
7 Types Of Medication Lockers
What is a medication locker? Medication lockers, also known as medication cabinets or pill lockers, are secure storage units designed…
Read More » -
22 June
Why You Should Get A Lockable Medicine Box (10 Benefits)
A lockable medicine box, also known as a medication lock box or a medicine safe, is a secure container designed…
Read More » -
21 June
Daily Low-Dose Aspirin Increased Anemia Risk in Older Individuals – New Study
Researchers have reported that aspirin not only increases the risk of anemia by over 20% in individuals aged 70 or…
Read More » -
21 June
Lodoco (Colchicine) Gets FDA Approval As The First Anti-Inflammatory Drug for Cardiovascular Disease
The FDA has approved Lodoco (colchicine) as the first anti-inflammatory drug for cardiovascular disease. Lodoco has been demonstrated to reduce…
Read More »